Form 4: Bioforce Nanosciences Holdings Director Sells Shares
Insider Transaction (Form 4)
Merle Ferguson, a Director of Bioforce Nanosciences Holdings, Inc., sold 26,700,000 shares of common stock on April 20, 2026 for $0.01 per share.
Summary
- Bona fide gift: acquired 20,580,000 Common Stock; Par Value $0.001 at $0.01 ($144,060) on April 20, 2026; holds 22,568,000 after (Direct).
- Bona fide gift: acquired 4,132,000 Common Stock; Par Value $0.001 at $0.00 ($4,132) on April 20, 2026; holds 26,700,000 after (Direct).
- Open-market sale: disposed of 26,700,000 Common Stock; Par Value $0.001 at $0.01 ($400,500) on April 22, 2026 (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $400,500 of stock on the open market.
Insider Transactions
Merle Ferguson — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-04-20 | Bona fide gift | Common Stock; Par Value $0.001 | 20,580,000 | $0 | $144.1K | 22,568,000 |
| 2026-04-20 | Bona fide gift | Common Stock; Par Value $0.001 | 4,132,000 | $0 | $4.1K | 26,700,000 |
| 2026-04-22 | Open-market sale | Common Stock; Par Value $0.001 | 26,700,000 | $0 | $400.5K | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-04-20 | Bona fide gift (20,580,000 shares) |
| 2026-04-20 | Bona fide gift (4,132,000 shares) |
| 2026-04-22 | Open-market sale (26,700,000 shares) |
Keywords
insider transaction, Form 4, BFNH, BIOFORCE NANOSCIENCES HOLDINGS, INC., bearish, Merle Ferguson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.